Indong, Kiarra Suzette G.

HRN: 22-29-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
CEFUROXIME 750MG (VIAL)
12/06/2022
12/12/2022
IV DRIP
335 Mg
Q8
ATP
Waiting Final Action 
02/17/2024
CEFUROXIME 750MG (VIAL)
02/17/2024
02/24/2024
IV
400mg
Q8H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: